Education, Science, Technology, Innovation and Life
Open Access
Sign In

A review of neuroprotective mechanisms of dexmedetomidine

Download as PDF

DOI: 10.23977/medsc.2023.040113 | Downloads: 11 | Views: 368

Author(s)

Wenxian An 1, Yaying Xie 2

Affiliation(s)

1 Department of Anesthesiology, Inner Mongolia Medical University, Hohhot, China
2 Department of Anesthesiology, the First Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China

Corresponding Author

Wenxian An

ABSTRACT

Dexmedetomidine (DEX) is a highly specific and effective α2-adrenergic receptor agonist. Due to its high protein binding rate, intravenous pumping can play a good role in sedation and hypnosis, analgesia, anti-anxiety, reducing inflammation, and so on, so it has been widely used in clinical anesthesia and basic research. In recent years, with the further study of dexmedetomidine, it has been found that it has a certain protective effect on nerve injury caused by various causes.

KEYWORDS

Dexmedetomidine, Neuroprotection, Mechanism, α2-adrenergic Receptor Agonist

CITE THIS PAPER

Wenxian An, Yaying Xie, A review of neuroprotective mechanisms of dexmedetomidine. MEDS Clinical Medicine (2023) Vol. 4: 78-86. DOI: http://dx.doi.org/10.23977/medsc.2023.040113.

REFERENCES

[1] Degos V, Charpentier TL, Chhor V, Brissaud O, Lebon S, Schwendimann L, Bednareck N, Passemard S, Mantz J, Gressens P. Neuroprotective effects of dexmedetomidine against glutamate agonist-induced neuronal cell death are related to increased astrocyte brain-derived neurotrophic factor expression. Anesthesiology. 2013 May; 118(5): 1123-32. 
[2] Liu YJ, Wang DY, Yang YJ, Lei WF. Effects and mechanism of dexmedetomidine on neuronal cell injury induced by hypoxia-ischemia. BMC Anesthesiol. 2017 Aug 30; 17(1):117.
[3] Song Wenying, Zheng Wei, Song Yulong, Ding Hui. Protective effect of dexmedetomidine on cognitive function and neural function in rats with cerebral ischemia reperfusion injury [J]. Journal of Clinical and Experimental Medicine, 2019, 18(01): 18-21.
[4] Do SH, Park SJ, Shin HJ, Paik HS, Zuo Z, Yoon HJ, Ryu JH. Dexmedetomidine increases the activity of excitatory amino acid transporter type 3 expressed in Xenopus oocytes: the involvement of protein kinase C and phosphatidylinositol 3-kinase. Eur J Pharmacol. 2014 Sep 5; 738: 8-13. 
[5] Liaquat Z, Xu X, Zilundu PLM, Fu R, Zhou L. The Current Role of Dexmedetomidine as Neuroprotective Agent: An Updated Review. Brain Sci. 2021 Jun 25; 11(7): 846.
[6] Zhao Y, He J, Yu N, et al. Mechanisms of Dexmedetomidine in Neuropathic Pain[J]. Frontiers in Neuroscience, 2020, 14.
[7] Zhao Qian, Yang Jian. Research progress on the mechanism of dexmedetomidine regulating apoptosis and pyrodeath in central nervous system [J]. Chinese Journal of Medicine, 2002, 17(05): 789-792.
[8] Tang Ying, Li Xinmei, Wang Xue, Zhang Zhijie, Chen Huayong, Wang Shilei. Right beauty holds the mi nerve protective effect of autophagy mechanism study [J]. Modern biomedical progress, 2020, 20 (21): 4019-4024 + 4067. 
[9] Yan M, Dai H, Ding T, Dai A, Zhang F, Yu L, Chen G, Chen Z. Effects of dexmedetomidine on the release of glial cell line-derived neurotrophic factor from rat astrocyte cells. Neurochem Int. 2011 Apr; 58(5): 549-57. 
[10] Wang Y, Han R, Zuo Z. Dexmedetomidine post-treatment induces neuroprotection via activation of extracellular signal-regulated kinase in rats with subarachnoid haemorrhage. Br J Anaesth. 2016 Mar; 116(3): 384-92. 
[11] Schoeler M, Loetscher PD, Rossaint R, Fahlenkamp AV, Eberhardt G, Rex S, Weis J, Coburn M. Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury. BMC Neurol. 2012 Apr 11; 12: 20.
[12] Chen BS, Peng H, Wu SN. Dexmedetomidine, an alpha2-adrenergic agonist, inhibits neuronal delayed-rectifier potassium current and sodium current. Br J Anaesth. 2009 Aug; 103(2): 244-54.
[13] Zhu Huichen, He Zhengyu, Wang Xiangrui. Neuroprotective effect of dexmedetomidine and its clinical application [J]. Shanghai Med, 2012, 35(08): 722-725.
[14] Mei B, Li J, Zuo Z. Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor. Brain Behav Immun. 2021 Jan; 91: 296-314.
[15] Luo Zi, Hu Xiaoling. Right beauty holds the mi on the research progress of anti-inflammatory effects in sepsis [J]. Chinese and foreign medical research, 2015, 13 (8): 159-161. 
[16] Akpınar H, Nazıroğlu M, Övey İS, Çiğ B, Akpınar O. The neuroprotective action of dexmedetomidine on apoptosis, calcium entry and oxidative stress in cerebral ischemia-induced rats: Contribution of TRPM2 and TRPV1 channels. Sci Rep. 2016 Nov 22; 6: 37196. 
[17] Sifringer M, von Haefen C, Krain M, Paeschke N, Bendix I, Bührer C, Spies CD, Endesfelder S. Neuroprotective effect of dexmedetomidine on hyperoxia-induced toxicity in the neonatal rat brain. Oxid Med Cell Longev. 2015; 2015: 530371. 
[18] Zhang F, Ding T, Yu L, Zhong Y, Dai H, Yan M. Dexmedetomidine protects against oxygen-glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K/AKT pathway in rat C6 glioma cells. J Pharm Pharmacol. 2012 Jan; 64(1): 120-7.
[19] Chi OZ, Hunter C, Liu X, Weiss HR. The effects of dexmedetomidine on regional cerebral blood flow and oxygen consumption during severe hemorrhagic hypotension in rats. Anesth Analg. 2011 Aug; 113(2): 349-55. 
[20] Wang Jiaoyan, Wang Jiangang, Zhang Wenjie, Wang Xin, Zhu Jian. Effects of dexmedetomidine on cerebrovascular diameter and cerebral oxygen metabolism in neurosurgery patients undergoing cerebral angiography [J]. Abstract the latest medical information, 2018, 17 (16): 23-24 + 27.
[21] Wan Mengning, Tian Zidan, Chen Yupei. Right beauty in the research progress of the mi will play a role of brain protection [J]. Journal of chongqing medical university, 2016, 9 (5): 533-536.
[22] Zhang X, Fang Y, Feng J, et al. Dexmedetomidine inhibits inflammatory reaction in the hippocampus of septic rats by suppressing NF-κB pathway [J]. Plos One, 2018, 13(5):e0196897.
[23] Wu L, Xi Y, Kong Q. Dexmedetomidine protects PC12 cells from oxidative damage through regulation of miR-199a/HIF-1α. Artif Cells Nanomed Biotechnol. 2020 Dec; 48(1): 506-514. 
[24] Zhu Y, Zhao H, Zhang W, Ma X, Liu Y. Dexmedetomidine attenuates neuronal injury induced by cerebral ischemia reperfusion by regulating miR 199a. Mol Med Rep. 2021 Aug; 24(2): 574. 
[25] Zhou L, Qin SJ, Gao X, Han JP, Hu B, Li M, Wu YQ, Ma X, Gu SL, Ma TF. Dexmedetomidine prevents post-ischemic LTP via presynaptic and postsynaptic mechanisms. Brain Res. 2015 Oct 5; 1622: 308-20. 
[26] Zhang L, Zhang P, Wang G, Zhang H, Zhang Y, Yu Y, Zhang M, Xiao J, Crespo P, Hell JW, Lin L, Huganir RL, Zhu JJ. Ras and Rap Signal Bidirectional Synaptic Plasticity via Distinct Subcellular Microdomains. Neuron. 2018 May 16; 98(4): 783-800.e4. 
[27] Wang Y, Chen K, Zhang T, et al. Update in Neuroprotective Effects of Dexmedetomidine[J]. Trauma and Critical Care Medicine, 2014.
[28] Xiao Y, Zhou L, Tu Y, Li Y, Liang Y, Zhang X, Lv J, Zhong Y, Xie Y. Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway. Neuropsychiatr Dis Treat. 2018 Aug 28; 14: 2191-2206. 
[29] Gong Z, Li J, Zhong Y, et al. Effects of dexmedetomidine on postoperative cognitive function in patients undergoing coronary artery bypass grafting [J]. Exp Ther Med, 2018, 16(6): 4685-4689.
[30] Zhang X, Wang J, Qian W, Zhao J, Sun L, Qian Y, Xiao H. Dexmedetomidine inhibits tumor necrosis factor-alpha and interleukin 6 in lipopolysaccharide-stimulated astrocytes by suppression of c-Jun N-terminal kinases. Inflammation. 2014 Jun; 37(3): 942-9. 
[31] Madore C, Yin Z, Leibowitz J, Butovsky O. Microglia, Lifestyle Stress, and Neurodegeneration. Immunity. 2020 Feb 18; 52(2): 222-240.
[32] Song J, Choi SM, Kim BC. Adiponectin Regulates the Polarization and Function of Microglia via PPAR-γ Signaling under Amyloid β Toxicity. Front Cell Neurosci. 2017 Mar 7; 11: 64. 
[33] Sun Z, Lin Y, Li Y, Ren T, Du G, Wang J, Jin X, Yang LC. The effect of dexmedetomidine on inflammatory inhibition and microglial polarization in BV-2 cells. Neurol Res. 2018 Oct; 40(10): 838-846. 
[34] Wang N, Nie H, Zhang Y, Han H, Wang S, Liu W, Tian K. Dexmedetomidine exerts cerebral protective effects against cerebral ischemic injury by promoting the polarization of M2 microglia via the Nrf2/HO-1/NLRP3 pathway. Inflamm Res. 2022 Jan; 71(1): 93-106. 
[35] Wang Wenhao, Liu Xingqiang. Significance of serum neuron-specific enolase levels in adult patients with traumatic brain injury [J]. Journal of Translational Medicine, 2002, 11(01): 1-4.
[36] Ternovykh Ivan, Chaykovskaya Alexandra, Topuzova Maria, Kovzelev Pavel, Makhanova Albina, Korotkova Daria, Kipkeeva Alina, Zatey Anna, Mikheeva Anna, Vavilova Tatiana, Vasilieva Elena, Simakov Kaium, Sergeeva Tatiana, Alekseeva Tatiana. Neuron-specific enolase as a biomarker of ischemic stroke [J]. Journal of the Neurological Sciences, 2021, 429(S). 
[37] Ruan Yucai, Xiao Xiaobing, Chen Shaoling, Deng Jianrong, Yang Zhi. Clinical study of S100B and neuron-specific enolase in children with Mycoplasma pneumoniae pneumonia complicated with central nervous system damage [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2019, 11(05): 404-407.
[38] Chen L J, Xue Q S, Yu B W. Neuroprotection and mechanisms of dexmedetomidine[J]. Chinese Pharmacological Bulletin, 2015.
[39] Li Y, Yu ZX, Ji MS, Yan J, Cai Y, Liu J, Yang HF, Jin ZC. A Pilot Study of the Use of Dexmedetomidine for the Control of Delirium by Reducing the Serum Concentrations of Brain-Derived Neurotrophic Factor, Neuron-Specific Enolase, and S100B in Polytrauma Patients. J Intensive Care Med. 2019 Aug; 34(8): 674-681.

Downloads: 3870
Visits: 167007

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.